| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c17f1d231514bccb11dc19893e79fedb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate |
2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2fd62d88e769608b2bd85557c55b5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde04c455045ab7ba4b93ec6db6e0570
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe72d5d038eccc06128a569f10cc98d2 |
| publicationDate |
2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019226186-A1 |
| titleOfInvention |
Composition and method to alleviate joint pain using hyaluronic acid and eggshell membrane components |
| abstract |
A dietary supplement composition is formulated in an oral dosage form and in a therapeutic amount to treat and alleviate symptoms of joint pain in an animal, and includes eggshell membrane, astaxanthin, and pro-inflammatory low molecular weight hyaluronic acid/hyaluronan having a molecular weight of 0.5 to 300 kilodaltons (kDa) and high molecular weight hyaluronic acid/hyaluronan having a molecular weight greater than 300 kDa. The high molecular weight hyaluronic acid/hyaluronan is greater than 50 percent of the total for the low and high molecular weight hyaluronic acid/hyaluronan and effective to modulate the low molecular weight hyaluronic acid/hyaluronan. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116711862-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115645367-A |
| priorityDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |